Valneva SE (VLA)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

€3.55

Buy

€3.57

arrow-up€0.074 (+2.12%)

Prices updated at 19 Dec 2025, 16:35 CET

Prices minimum 15 mins delay

Prices in EUR

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes two vaccines for travelers; one for the prevention of Japanese encephalitis (IXIARO) and the second (DUKORAL) for the prevention of cholera and diarrhoea.

FTSE EuroFirst 300

0.43%

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Biotechnology

Chairman

Ms. Anne-Marie Graffin

CEO

Mr. Thomas Lingelbach

Most recent earnings

31 Dec 2024

Fiscal year end

31 Dec 2024

Employees

713

Head office

6 Rue Alain Bombard

Saint-Herblain

France

44800

+33 228073710

investors.relations@vivalis.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Mr. James R. Sulat Vice Chairman of the Board	0.11m
Mr. Franck Grimaud Chief Business Officer	0.29m
Mr. Thomas Lingelbach Director, President and Chief Executive Officer	0.57m
Ms. Mailys Ferrere Director	-
Mr. Peter Buhler Chief Financial Officer	0.41m
Ms. Anne-Marie Graffin Chairman of the Board	0.12m
Dr. Juan Carlos Jaramillo, M.D. Chief Medical Officer	0.38m
Ms. Daniele Guyot-Caparros Independent Director	0.03m
Ms. Dipal Patel Chief Commercial Officer	0.38m
Mr. James Connolly Independent Director	0.09m
Mr. Vincent Dequenne Chief Operating Officer	-
Ms. Petra Pesendorfer Chief People Officer	-
Dr. Kathrin Jansen, PhD Director	0.08m
Ms. Hanneke Schuitemaker Chief Scientific Officer	-
Ms. Kendra Wergin General Counsel and Corporate Secretary	-

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
Candriam - Belgian Branch	2,397,561
Candriam Eqs L Biotechnology	2,397,561
BlackRock Fund Advisors	1,506,290
Amundi Austria GmbH	1,437,455
Amundi Öko Sozial Stock	962,824

Director dealings

Date chevron-l-regular chevron-r-regular	Action
No data

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.